We showed that RIPK4 is involved in signal transduction through the NFκB [24] and Wnt/β-catenin pathways, regulating the Wnt3A-induced invasive potential of melanoma cells and the growth of xenografts in mice [25]. The gene discussed is RIPK4; the disease is melanoma.